Dmitri Bobilev
Overview
Explore the profile of Dmitri Bobilev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Davar D, Morrison R, Dzutsev A, Karunamurthy A, Chauvin J, Amatore F, et al.
Cancer Cell
. 2024 Nov;
42(11):1898-1918.e12.
PMID: 39486411
Intratumoral TLR9 agonists and anti-PD-1 produce clinical responses and broad immune activation. We conducted a single-arm study of neoadjuvant TLR9 agonist vidutolimod combined with anti-PD-1 nivolumab in high-risk resectable melanoma....
2.
Louie T, Golan Y, Khanna S, Bobilev D, Erpelding N, Fratazzi C, et al.
JAMA
. 2023 Apr;
329(16):1356-1366.
PMID: 37060545
Importance: The effect of rationally defined nonpathogenic, nontoxigenic, commensal strains of Clostridia on prevention of Clostridioides difficile infection (CDI) is unknown. Objective: To determine the efficacy of VE303, a defined...
3.
DSouza M, Menon R, Crossette E, Bhattarai S, Schneider J, Kim Y, et al.
Cell Host Microbe
. 2022 Apr;
30(4):583-598.e8.
PMID: 35421353
Manipulation of the gut microbiota via fecal microbiota transplantation (FMT) has shown clinical promise in diseases such as recurrent Clostridioides difficile infection (rCDI). However, the variable nature of this approach...
4.
Lin C, Arkenau H, Lu S, Sachdev J, de Castro Carpeno J, Mita M, et al.
Br J Cancer
. 2019 Jun;
121(2):131-138.
PMID: 31217479
Background: Anaplastic lymphoma kinase (ALK) gene rearrangements are oncogenic drivers in non-small-cell lung cancer (NSCLC). TSR-011 is a dual ALK and tropomyosin-related kinase (TRK) inhibitor, active against ALK inhibitor resistant...
5.
Konstantinopoulos P, Waggoner S, Vidal G, Mita M, Moroney J, Holloway R, et al.
JAMA Oncol
. 2019 Jun;
5(8):1141-1149.
PMID: 31194228
Importance: Patients with recurrent ovarian carcinoma frequently develop resistance to platinum-based chemotherapy, at which time treatment options become limited. Objective: To evaluate the poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitor niraparib combined...
6.
Tokar M, Meirovich M, Bobilev D, Mermershtain W
Indian J Med Paediatr Oncol
. 2016 May;
37(2):112-5.
PMID: 27168710
Objective: The aim was to investigate the value of postoperative brachytherapy for patients with Stage IB, Grade 2 endometrial carcinoma. Patients And Methods: Forty-six patients with Stage IB, Grade 2...
7.
Girard E, Ditzler S, Lee D, Richards A, Yagle K, Park J, et al.
Neuro Oncol
. 2014 Aug;
17(1):107-15.
PMID: 25140037
Background: There is an unmet need in the treatment of pediatric brain tumors for chemotherapy that is efficacious, avoids damage to the developing brain, and crosses the blood-brain barrier. These...
8.
Peleg R, Bobilev D, Priel E
Int J Oncol
. 2014 Jan;
44(3):934-42.
PMID: 24399039
Topoisomerases are essential nuclear enzymes that work to resolve topological problems that normally occur during DNA metabolism. Their involvement in crucial DNA associated-processes, such as replication, transcription and repair, mark...
9.
Tokar M, Bobilev D, Ariad S, Geffen D
Isr Med Assoc J
. 2007 Jan;
8(12):853-5.
PMID: 17214103
Background: Disseminated intravascular coagulation associated with malignant bone marrow involvement has been described as a rare complication of gastric carcinoma and most patients die within 1-4 weeks. Effective chemotherapy of...
10.
Tokar M, Bobilev D, Zalmanov S, Geffen D, Walfisch S
Onkologie
. 2006 Mar;
29(1-2):30-2.
PMID: 16514253
Background: We report on a patient with squamous cell anal carcinoma and liver metastases, who underwent multimodal treatment for cure, consisting of repeated partial hepatectomy in combination with chemoradiotherapy. Patients...